How many insider trades does FilingIQ track for INMB?

FilingIQ tracks 195 Form 4 insider transactions for INMB (Inmune Bio, Inc.), covering filings from May 2, 2019 onwards. 6 of those were filed in the last 90 days.

Are INMB insiders net buyers or net sellers?

Across the full Form 4 history for INMB, 47 transactions (24%) were open-market purchases and 23 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does INMB insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is INMB in?

Inmune Bio, Inc. (INMB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $32.43M.

INMB insider trading

NasdaqCM Healthcare

Inmune Bio, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

195

Last 90 days

Buys / sells

24% / 12%

Market cap

$32.43M

About Inmune Bio, Inc.

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

Company website: www.inmunebio.com

INMB insider activity at a glance

FilingIQ has scored 195 insider transactions for INMB since May 2, 2019. The most recent filing in our index is dated Jul 2, 2026.

Across the full history, 47 open-market purchases and 23 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on INMB insider trades is 52.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live INMB trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,099

UNITED THERAPEUTICS Corp

APLS 274

Apellis Pharmaceuticals, Inc.

KYMR 232

Kymera Therapeutics, Inc.

GH 194

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for INMB?: FilingIQ tracks 195 Form 4 insider transactions for INMB (Inmune Bio, Inc.), covering filings from May 2, 2019 onwards. 6 of those were filed in the last 90 days.
Are INMB insiders net buyers or net sellers?: Across the full Form 4 history for INMB, 47 transactions (24%) were open-market purchases and 23 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does INMB insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is INMB in?: Inmune Bio, Inc. (INMB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $32.43M.

Methodology & sources

Every INMB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.